SG Americas Securities’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $55K | Sell |
14,157
-227,724
| -94% | -$831K | ﹤0.01% | 3199 |
|
|
2026
Q1 | $955K | Buy |
241,881
+53,836
| +29% | +$271K | ﹤0.01% | 1785 |
|
|
2025
Q4 | $1.27M | Buy |
188,045
+26,085
| +16% | +$183K | ﹤0.01% | 1812 |
|
|
2025
Q3 | $1.13M | Buy |
161,960
+130,769
| +419% | +$909K | ﹤0.01% | 1350 |
|
|
2025
Q2 | $191K | Sell |
31,191
-23,164
| -43% | -$154K | ﹤0.01% | 2280 |
|
|
2025
Q1 | $413K | Sell |
54,355
-29,030
| -35% | -$243K | ﹤0.01% | 1935 |
|
|
2024
Q4 | $802K | Buy |
83,385
+37,031
| +80% | +$288K | ﹤0.01% | 980 |
|
|
2024
Q3 | $274K | Buy |
46,354
+23,560
| +103% | +$156K | ﹤0.01% | 2230 |
|
|
2024
Q2 | $158K | Sell |
22,794
-40,261
| -64% | -$283K | ﹤0.01% | 2290 |
|
|
2024
Q1 | $486K | Sell |
63,055
-18,585
| -23% | -$149K | ﹤0.01% | 1439 |
|
|
2023
Q4 | $716K | Buy |
81,640
+41,970
| +106% | +$307K | 0.01% | 1239 |
|
|
2023
Q3 | $289K | Buy |
+39,670
| New | +$296K | ﹤0.01% | 2097 |
|
|
2023
Q2 | – | Sell |
-62,359
| Closed | -$213K | – | 2813 |
|
|
2023
Q1 | $213K | Buy |
62,359
+13,418
| +27% | +$52K | ﹤0.01% | 2373 |
|
|
2022
Q4 | $136K | Buy |
48,941
+8,061
| +20% | +$24.1K | ﹤0.01% | 2505 |
|
|
2022
Q3 | $117K | Sell |
40,880
-28,245
| -41% | -$100K | ﹤0.01% | 2744 |
|
|
2022
Q2 | $240K | Buy |
+69,125
| New | +$271K | ﹤0.01% | 2538 |
|
|
2022
Q1 | – | Sell |
-38,749
| Closed | -$234K | – | 3257 |
|
|
2021
Q4 | $234K | Sell |
38,749
-18,065
| -32% | -$125K | ﹤0.01% | 2593 |
|
|
2021
Q3 | $344K | Buy |
+56,814
| New | +$640K | ﹤0.01% | 2819 |
|
|
2021
Q1 | – | Sell |
-11,325
| Closed | -$103K | – | 3439 |
|
|
2020
Q4 | $103K | Buy |
+11,325
| New | +$81.5K | ﹤0.01% | 3028 |
|
|
2018
Q4 | – | Sell |
-42,831
| Closed | -$265K | – | 3211 |
|
|
2018
Q3 | $265K | Buy |
42,831
+31,057
| +264% | +$140K | ﹤0.01% | 2427 |
|
|
2018
Q2 | $75K | Sell |
11,774
-19,479
| -62% | -$139K | ﹤0.01% | 3115 |
|
|
2018
Q1 | $218K | Buy |
31,253
+6,329
| +25% | +$73.7K | ﹤0.01% | 2379 |
|
|
2017
Q4 | $314K | Sell |
24,924
-19,682
| -44% | -$240K | ﹤0.01% | 2149 |
|
|
2017
Q3 | $530K | Buy |
44,606
+10,963
| +33% | +$163K | ﹤0.01% | 1800 |
|
|
2017
Q2 | $504K | Buy |
+33,643
| New | +$449K | ﹤0.01% | 1861 |
|
|
2016
Q4 | – | Sell |
-12,573
| Closed | -$108K | – | 3332 |
|
|
2016
Q3 | $108K | Buy |
+12,573
| New | +$99.6K | ﹤0.01% | 3017 |
|
|
2016
Q2 | – | Sell |
-11,406
| Closed | -$100K | – | 2840 |
|
|
2016
Q1 | $100K | Buy |
+11,406
| New | +$94.8K | ﹤0.01% | 2628 |
|
|
2015
Q3 | – | Sell |
-15,712
| Closed | -$182K | – | 2462 |
|
|
2015
Q2 | $182K | Buy |
+15,712
| New | +$162K | ﹤0.01% | 2023 |
|
|
2014
Q3 | – | Sell |
-20,823
| Closed | -$148K | – | 2758 |
|
|
2014
Q2 | $148K | Buy |
+20,823
| New | +$122K | ﹤0.01% | 2191 |
|
|
2013
Q4 | – | Sell |
-15,080
| Closed | -$63K | – | 2852 |
|
|
2013
Q3 | $63K | Buy |
+15,080
| New | +$83.1K | ﹤0.01% | 2765 |
|
Other funds holding MDXG
EWM
TI
NCM
PCMI
SG Americas Securities's MDXG Position: Q2 2026 in Review
SG Americas Securities reduced its MiMedx Group (MDXG) stake by 94% in Q2 2026, selling an estimated $831K and leaving 14,157 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #3199.
SG Americas Securities first reported a position in MDXG in Q3 2013 and has held it in 30 quarters since. The position peaked at $1.27M in Q4 2025. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.
- SG Americas Securities held 14,157 shares of MiMedx Group worth $55K as of Q2 2026.
- SG Americas Securities sold 227,724 MiMedx Group shares in Q2 2026, an estimated $831K.
- MiMedx Group made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3199 holding.
- SG Americas Securities first reported a position in MiMedx Group in Q3 2013 and has held it in 30 quarters since.
- SG Americas Securities's MiMedx Group position peaked at $1.27M in Q4 2025.
- 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.